A continuación encontrará estudios de casos, seminarios web, blogs y comunicados de prensa en los que compartimos información valiosa sobre los ensayos clínicos descentralizados.
Medical device trials are inherently challenging, particularly in women's health. But, within the context of a pandemic, the hurdles may seem insurmountable.
When it comes to decentralized clinical trials (DCTs), the pharmaceutical industry finds itself at a crossroads.
Digital instruments such as sensors and wearables are transforming the industry’s definition of accuracy in three measures: volume, practicality, and precision.
While there's broad agreement on the gap between white and non-white participation in clinical trial enrollment, the number of non-white patients enrolled in clinical trials for general population studies is still quite low. But why?
For patients with rare, incurable, or life-threatening diseases, clinical trials can offer new hope. Cancer patients, specifically, are often highly motivated to participate in research, particularly when they have an advanced or treatment-resistant form of cancer. Find out how decentralized clinical trials reach patients in the comfort of their homes.